Does Hydroxychloroquine Reduce Mortality for COVID-19?

Overview

Journal Eur J Intern Med

Specialty General Medicine

Date 2020 Oct 31

PMID 33127218

Citations 2

Authors

Silvano Gallus

Antonio Clavenna

Alessandra Lugo

Affiliations

Soon will be listed here.

Citing Articles

Drug Repurposing for COVID-19: A Review and a Novel Strategy to Identify New Targets and Potential Drug Candidates.

Rodrigues L, Bento Cunha R, Vassilevskaia T, Viveiros M, Cunha C Molecules. 2022; 27(9).

PMID: 35566073 PMC: 9099573. DOI: 10.3390/molecules27092723.

An Up-to-Date Overview of Therapeutic Agents for the Treatment of COVID-19 Disease.

Belete T Clin Pharmacol. 2020; 12:203-212.

PMID: 33363416 PMC: 7753885. DOI: 10.2147/CPAA.S284809.

References

Horby P, Lim W, Emberson J, Mafham M, Bell J, Linsell L . Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2020; 384(8):693-704. PMC: 7383595. DOI: 10.1056/NEJMoa2021436. View

. Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study. Eur J Intern Med. 2020; 82:38-47. PMC: 7446618. DOI: 10.1016/j.ejim.2020.08.019. View

Hernandez A, Roman Y, Pasupuleti V, Barboza J, White C . Hydroxychloroquine or Chloroquine for Treatment or Prophylaxis of COVID-19: A Living Systematic Review. Ann Intern Med. 2020; 173(4):287-296. DOI: 10.7326/M20-2496. View

Mercuro N, Yen C, Shim D, Maher T, McCoy C, Zimetbaum P . Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(9):1036-1041. PMC: 7195692. DOI: 10.1001/jamacardio.2020.1834. View

Shukla A, Wagle Shukla A . Expanding horizons for clinical applications of chloroquine, hydroxychloroquine, and related structural analogues. Drugs Context. 2019; 8. PMC: 6905642. DOI: 10.7573/dic.2019-9-1. View

Boulware D, Pullen M, Bangdiwala A, Pastick K, Lofgren S, Okafor E . A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020; 383(6):517-525. PMC: 7289276. DOI: 10.1056/NEJMoa2016638. View

Axfors C, Schmitt A, Janiaud P, Vant Hooft J, Abd-Elsalam S, Abdo E . Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials. Nat Commun. 2021; 12(1):2349. PMC: 8050319. DOI: 10.1038/s41467-021-22446-z. View

Nguyen L, Dolladille C, Drici M, Fenioux C, Alexandre J, Mira J . Cardiovascular Toxicities Associated With Hydroxychloroquine and Azithromycin: An Analysis of the World Health Organization Pharmacovigilance Database. Circulation. 2020; 142(3):303-305. PMC: 7365677. DOI: 10.1161/CIRCULATIONAHA.120.048238. View

Hernandez A, Roman Y, Pasupuleti V, Barboza J, White C . Update Alert 3: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19. Ann Intern Med. 2020; 173(11):W156-W157. PMC: 7596739. DOI: 10.7326/L20-1257. View

10.

Das R, Jaiswal N, Dev N, Jaiswal N, Naik S, Sankar J . Efficacy and Safety of Anti-malarial Drugs (Chloroquine and Hydroxy-Chloroquine) in Treatment of COVID-19 Infection: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2020; 7:482. PMC: 7403461. DOI: 10.3389/fmed.2020.00482. View

11.

Sterne J, Murthy S, Diaz J, Slutsky A, Villar J, Angus D . Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis. JAMA. 2020; 324(13):1330-1341. PMC: 7489434. DOI: 10.1001/jama.2020.17023. View

12.

Bessiere F, Roccia H, Deliniere A, Charriere R, Chevalier P, Argaud L . Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit. JAMA Cardiol. 2020; 5(9):1067-1069. PMC: 7195693. DOI: 10.1001/jamacardio.2020.1787. View

13.

Bonow R, Hernandez A, Turakhia M . Hydroxychloroquine, Coronavirus Disease 2019, and QT Prolongation. JAMA Cardiol. 2020; 5(9):986-987. DOI: 10.1001/jamacardio.2020.1782. View

14.

Thomson K, Nachlis H . Emergency Use Authorizations During the COVID-19 Pandemic: Lessons From Hydroxychloroquine for Vaccine Authorization and Approval. JAMA. 2020; 324(13):1282-1283. DOI: 10.1001/jama.2020.16253. View